期刊文献+

TIPS术后支架再狭窄或闭塞的介入治疗 被引量:6

Interventional treatment of stent restenosis or occlusion after transjugular intrahepatic portosystemic shunt
下载PDF
导出
摘要 目的 总结经颈静脉肝内门体分流术( transjugular intrahepatic portosystemic shunt,TIPS)术后支架再狭窄或闭塞的介入治疗.方法 选取2009年1月至2011年12月期间首都医科大学附属北京世纪坛医院介入病房收治的20例TIPS术后支架再狭窄或闭塞的患者,男性15例,女性5例,患者年龄27~58岁,平均年龄48岁.术前门静脉多普勒超声检查及术中数字减影血管造影(digital subtraction angiography,DSA)证实支架再狭窄的患者12例、支架闭塞的患者8例,20例患者所用均为裸支架.经单纯球囊扩张治疗的4例,球囊扩张后再次置入支架治疗的11例,再次穿刺行TIPS再建分流道治疗的5例.结果 术前平均门静脉压力由(3.94±0.52)kPa降至术后的(2.55±0.46)kPa(P〈0.05),术后1周内3例出现肝性脑病药物治疗后好转,术后口服华法林抗凝治疗,随访1.5年超声检查未见支架再狭窄或闭塞发生.结论 TIPS术后支架存在一定再狭窄或闭塞率,应用介入技术可以再次降低门静脉压力延长患者生存期具有极高的临床应用价值. Objective To summarize the interventional treatment strategy of stem restenosis or occlusion after transjugular intrahepatic portosystemic shunt (TIPS) . Methods The data collected from 20 patients (10 males and 5 females, aged 27 -58 years, averaged 48 years) with stent restenosis or occlusion after TIPS from Jan. 2009 to Dec. 2011 were retrospectively analyzed. 12 patients with stent restenosis and 8 patients with stent occlusion were confirmed by uhrasonngraphy before surgery and intraoperative DSA. All patients were used bare metal stent. 4 patients were performed ballon dilation, 11 patients were re -stented after ballon dilation, and 5 patients accepted the second Tips to reconstruct the shut. Results Free portal pressure (FPP) was reduced from(3.94 ±0.52)kPa to(2.55 ±0.46)kPa (P 〈 0.05), 3 patients with hepatic coma improved after drug treatment within one week postoperatively. All patients underwent warfarin anticoagulation after intervention. There was no stent restenosis or occlusion during follow - up of 1.5 years. Conclusion The shunt stent has a certain rate of restenosis or occlusion after TIPS, but the prior stem can be expended and the shunt can be reconstructed with intervemional techniques, it has the extremely application value in reducing portal pressure and extending the survival of patients.
出处 《首都医科大学学报》 CAS 2014年第1期136-139,共4页 Journal of Capital Medical University
关键词 颈静脉肝内门体分流术 支架 狭窄 闭塞 介入治疗 transjugular intrahepatic portosystemic shunt stent restenosis occlusion interventional treatment
  • 相关文献

参考文献9

  • 1Richter G M,Noeldge G,Palmaz J C,et al.Transjugular intrahepatic portacaval stent shunt:preliminary clinical results[J].Radiology,1990,174(32):1027-1030. 被引量:1
  • 2陈斌,范文哲,向贤宏,杨建勇.美国肝病研究学会(AASLD)实践指南:经颈静脉肝内门体分流术(TIPS)在治疗门脉高压症中的作用[J].影像诊断与介入放射学,2010,19(4):242-249. 被引量:25
  • 3房殿春,陈磊.经颈静脉肝内门体分流术治疗门静脉高压症[J].中华肝脏病杂志,2009,17(4):244-246. 被引量:11
  • 4Jung H S,Kalva S P,Greenfield A J,et al.TIPS:comparison of shunt patency and clinical outcomes between bare stents and expanded polytewafluoroethylenestent-grafts[J].J Vase Interv Radiol,2009,20:180-185. 被引量:1
  • 5Garcia-Pagan J C,Caca K,Bureau C,et al.Early use of TIPS in patients with cirrhosis and variceal bleeding[J].N Engl J Med,2010,362(25):2370-2379. 被引量:1
  • 6Lim Y S,Larson T S,Benson J T,et al.Serum sodium,renal function,and survival of patients with end-stage liver disease[J].J Hepatol,2010,52(4):523-528. 被引量:1
  • 7Zheng M,Chen Y,Bai J,et al.Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients:meta-analysis update[J].J Clin Gastroenterol,2008,42 (5):507-516. 被引量:1
  • 8Narahara Y,Kanazawa H,Fukuda T,et al.Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function:a prospective randomized trial[J].J Gastroenterol,2011,46(1):78-85. 被引量:1
  • 9陈炜,孙井来,石文海,王振堂,叶华,郝强,杨继金,袁敏.介入治疗严重并发症的原因分析及对策[J].中国煤炭工业医学杂志,2011,14(7):955-958. 被引量:2

二级参考文献32

  • 1张火俊,杨继金,田建明,生晶,袁敏,张峰,相成,陈炜,郝强.肝癌肝动脉栓塞化疗术后糖尿病的发生与治疗[J].介入放射学杂志,2006,15(6):374-376. 被引量:8
  • 2Gil A, Martfnez-Regueira F, Hernaindez-Lizoain JL, et al. The role of transjugular intrahepatic portosystemic shunt prior to abdominal tumoral surgery in cirrhotic patients with portal hypertension. Eur J Surg Oncol, 2004, 30: 46-52. 被引量:1
  • 3Salerno F, Gerbes A, Ginbs P, et al. Diagnosis, prevention and treat-ment of hepatorenal syndrome in cirrhosis. Gut, 2007, 56: 1310- 1318. 被引量:1
  • 4Boyer TD, Haskal ZJ; American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology, 2005, 41: 386-400. 被引量:1
  • 5Zheng M, Chen Y, Bai J, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update. J Clin Gastroenterol, 2008, 42:507-516. 被引量:1
  • 6Lo GH, Liang HL, Chen WC, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy, 2007, 39: 679-685. 被引量:1
  • 7Biecker E, Roth F, Heller J, et al. Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis. Eur J Gastroenterol Hepatol, 2007, 19: 846-852. 被引量:1
  • 8Chung HH, Razavi MK, Sze DY, et al. Portosystemic pressure gradient daring transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications? J Gastroenterol Hepatol, 2008, 23: 95-101. 被引量:1
  • 9Boyer TD, Henderson JM, Heerey AM, et al. Cost of preventing variceal rehleeding with transjugnlar intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol, 2008, 48: 407-414. 被引量:1
  • 10Kochar N, Tripathi D, McAvoy NC, et al. Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther, 2008, 28: 294-303. 被引量:1

共引文献33

同被引文献49

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部